# Buccal Misoprostol and Intravenous Tranexamic Acid During Emergent Cesarean Delivery

> **NCT03777696** · NA · UNKNOWN · sponsor: **hany farouk** · enrollment: 300 (estimated)

## Conditions studied

- Cesarean Section Complications

## Interventions

- **DRUG:** Misoprostol
- **DRUG:** TA
- **DRUG:** placebo to misoprostol
- **DRUG:** placebo to TA

## Key facts

- **NCT ID:** NCT03777696
- **Lead sponsor:** hany farouk
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-01
- **Primary completion:** 2020-12-31
- **Final completion:** 2021-01-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2019-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03777696

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03777696, "Buccal Misoprostol and Intravenous Tranexamic Acid During Emergent Cesarean Delivery". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03777696. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*